Filtered By:
Management: Economics

This page shows you your search results in order of relevance.

Order by Relevance | Date

Total 211 results found since Jan 2013.

The economics of drug allergy
Purpose of review As drug allergy research aims to inform clinical practice, implementation of best practices may be influenced by financial resources required to incorporate new interventions and the resulting clinical and economic returns on those resource investments. The present review summarizes new insights into the economics of drug allergy over the past year. Recent findings While considering economic implications of recent drug allergy research, many studies have addressed different contextual factors related to the setting, provider, or outcomes. Advances in technology have enabled specialized allergists to ...
Source: Current Opinion in Allergy and Clinical Immunology - June 25, 2020 Category: Allergy & Immunology Tags: SKIN ALLERGY: Edited by Thomas Werfel and Torsten Zuberbier Source Type: research

Food allergy trends at the crossing among socio-economics, history and geography
Purpose of review The epidemiology of food allergy did inspire theories on the reasons for the recent surge of the disease. We offer here a reasoned review on the relationships between the trajectories of human development and the trend of the food allergy epidemics. Recent findings The exponential trend of the frequency of food allergy paralleled the explosive acceleration of the human development over the last few decades. Dietary factors have been indicated as responsible for these trends and targeted for potential preventive strategies. Other socio-economic factors have been related to this evolution: solar exposu...
Source: Current Opinion in Allergy and Clinical Immunology - April 26, 2018 Category: Allergy & Immunology Tags: FOOD ALLERGY: Edited by Alessandro Fiocchi and Motohiro Ebisawa Source Type: research

Single-step direct drug provocation testing is safe for de-labelling selected "non-low-risk" penicillin allergy labels
CONCLUSION: In our cohort, direct single-step DPT was safe with only 6 patients with "non-low risk" allergy experiencing benign reactions. We hope further study can be performed into single-step direct DPT for interrogating "non-low risk" penicillin allergy labels.PMID:33865989 | DOI:10.1016/j.anai.2021.04.008
Source: Annals of Allergy, Asthma and Immunology - April 18, 2021 Category: Allergy & Immunology Authors: Jamma Li Vera Cvetanovski B Nursing Suran Fernando Source Type: research

A behavioral economics intervention to encourage epinephrine-carrying among food-allergic adults: a randomized controlled trial.
CONCLUSION: Although the intervention and control groups reported favorable impressions of text message-based reminder systems, the intervention group performed significantly better than the control group on a photograph-based measurement of epinephrine carriage. There remained ample room for improvement in the 2 groups given the goal of consistent, uninterrupted epinephrine carriage by people with potentially life-threatening food allergies. TRIAL REGISTRATION: https://clinicaltrials.gov; NCT02354729. PMID: 26093776 [PubMed - as supplied by publisher]
Source: Annals of Allergy, Asthma and Immunology - June 17, 2015 Category: Allergy & Immunology Authors: Cannuscio CC, Dupuis R, Graves A, Seymour JW, Kounaves S, Strupp E, Leri D, Frasso R, Grande D, Meisel ZF Tags: Ann Allergy Asthma Immunol Source Type: research

Single-step direct drug provocation testing is safe for de-labelling selected “non-low-risk” penicillin allergy labels
Penicillin allergy labels are prevalent, and removal of incorrect labels improves patient outcomes and health economics. Labels may be classified as "low-risk", or "non-lowrisk", the latter chiefly where symptoms suggest IgE-mediated etiology. Traditionally, "non-low-risk" allergy labels are assessed by penicillin skin testing followed by graded multi-step penicillin drug provocation testing (DPT).
Source: Annals of Allergy, Asthma and Immunology - April 15, 2021 Category: Allergy & Immunology Authors: Jamma Li, Vera Cvetanovski, B. Nursing, Suran Fernando Source Type: research

Single-step direct drug provocation testing is safe for delabelling selected non –low-risk penicillin allergy labels
Penicillin allergy labels are prevalent, and removal of incorrect labels improves patient outcomes and health economics. Labels may be classified as “low-risk” or “non–low-risk,” of which the symptoms of the latter chiefly suggest immunoglobulin E–mediated etiology. Traditionally, “non–low-risk” allergy labels are evaluated by penicillin skin testing followed by graded multistep penicillin drug provocation testing (DPT).
Source: Annals of Allergy, Asthma and Immunology - April 15, 2021 Category: Allergy & Immunology Authors: Jamma Li, Vera Cvetanovski, Suran Fernando Source Type: research

Follow-up of penicillin allergy labels 1 year after successful penicillin delabeling
Penicillin allergy delabeling confers many benefits, including reduced patient morbidity and mortality and improved health economics. Reports suggest that both patients and clinicians often remain hesitant to take and prescribe penicillins, respectively, after penicillin delabeling. However, follow-up of an individual's penicillin allergy label and incorporation of this into relevant health care records after delabeling have not been well studied in the Australian population.
Source: Annals of Allergy, Asthma and Immunology - September 15, 2022 Category: Allergy & Immunology Authors: Trisha Pinto, Jamma Li, Therese Boyle, Reina Zaragoza, Suran L. Fernando Tags: Original Article Source Type: research

Allergy immunotherapy: what is the evidence for cost saving?
Purpose of reviewGiven the widespread prevalence of allergic disease, its substantially associated clinical and economic burden, the unique disease-modifying benefits of allergy immunotherapy (AIT), and increased availability of sublingual immunotherapy (SLIT), a critical update of the evidence for AIT-related cost savings [for both subcutaneous immunotherapy (SCIT) and SLIT] is particularly relevant and timely. The present article reviews the evidence for SCIT-related and SLIT-related cost savings derived from a systematic review of the published literature. Recent findingsExamined were 24 publications pertaining to the h...
Source: Current Opinion in Allergy and Clinical Immunology - May 23, 2013 Category: Allergy & Immunology Tags: PHARMACOTHERAPY AND EVIDENCE BASED MEDICINE: Edited by David A. Khan and Enrico Compalati Source Type: research

The Combined Usage of Cor a 9 And Cor a 14 In Hazelnut Allergy Diagnosis Could Bring About Substantial Cost Savings To US Payors And Caregivers: a Population-Based Simulation Study
Hazelnut allergy (HA) accurate diagnosis is crucial: undetected patients may incur in severe reactions, while over-diagnosis brings about avoidable costs to Payors and anxiety in patients. As Component-Resolved Diagnosis (CRD) using Cora9 and Cora14 could be useful in HA diagnosis, this theoretical study aims at benchmarking these components when used alone or together. Results are input to a health economics model to quantify the economic impact of HA when various CRD paradigms are simulated in the US.
Source: Journal of Allergy and Clinical Immunology - January 31, 2020 Category: Allergy & Immunology Authors: Barbara Mascialino, Esben Eller, Magnus Borres Source Type: research

Economic burden of severe asthma in Turkey: a cost of illness study from payer perspective.
Conclusions.In conclusion, our findings indicate that managing patients with severe asthma pose a considerable burden to health economics in Turkey, with medications as the main cost driver. PMID: 32372589 [PubMed - as supplied by publisher]
Source: European Annals of Allergy and Clinical Immunology - May 8, 2020 Category: Allergy & Immunology Tags: Eur Ann Allergy Clin Immunol Source Type: research

Health sector costs of self-reported food allergy in Europe: a patient-based cost of illness study
Conclusions: Food allergy is associated with higher health care costs. Severity of allergic symptoms is a key explanatory factor.
Source: The European Journal of Public Health - September 26, 2013 Category: Journals (General) Authors: Fox, M., Mugford, M., Voordouw, J., Cornelisse-Vermaat, J., Antonides, G., de la Hoz Caballer, B., Cerecedo, I., Zamora, J., Rokicka, E., Jewczak, M., Clark, A. B., Kowalski, M. L., Papadopoulos, N., Knulst, A. C., Seneviratne, S., Belohlavkova, S., Asero Tags: Food and nutrition Source Type: research